pertuzumab,pembrolizumab,dostarlimab,talazoparib,durvalumab,trastuzumab,olaparib,paclitaxel,neratinib,cemiplimab,ganetespib,irinotecan,tucatinib
gsk,bms,amgen,astrazeneca,daiichi sankyo,merck,roche
['i-spy', 'breast']
absolutely thrilled to present remarkable data from the i-spy2 trial at #asco2022 about molecular subtypes in hr+/her2- early stage breast cancer. so grateful to the best mentor ever and to and the i-spy2 team for the opportunity. excited for i-spy2.2! 
@UCSF Hematology/Oncology Fellow | Interested in breast cancer clinical/translational research | Author of Huppert’s Notes | Tweets my own